Copyright © Inderes 2011 - present. All rights reserved.

Magle Chemoswed Holding

27.4

 

SEK

Less than 1K followers

MAGLE

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

-4.86%
+1.48%
-12.18%
-21.26%
-17.47%
-15.1%
+20.65%
-
+36.36%

The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes three operational areas. Magle Chemoswed, a contract development and manufacturing organization (CDMO). Magle PharmaCept, an established sales and marketing company for the development and direct sales of the Groups medical technology products, and Magle Biopolymers A/S, a specialized manufacturing organization of Dextran technology.

Read more
Market cap
562.14M SEK
Turnover
-
Revenue
236.04M
EBIT %
9.84 %
P/E
0.62
Dividend yield-%
-
Financial calendar
1.8
2025

Interim report Q2'25

31.10
2025

Interim report Q3'25

27.2
2026

Annual report '25

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.